• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫热休克蛋白90及其抑制剂格尔德霉素的抗疟活性

The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin.

作者信息

Kumar Rajinder, Musiyenko Alla, Barik Sailen

机构信息

Department of Biochemistry and Molecular Biology (MSB 2370), University of South Alabama, College of Medicine, 307 University Blvd, Mobile, AL 36688-0002, USA.

出版信息

Malar J. 2003 Sep 15;2:30. doi: 10.1186/1475-2875-2-30.

DOI:10.1186/1475-2875-2-30
PMID:14514358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC201030/
Abstract

BACKGROUND

The naturally occurring benzoquinone ansamycin compound, geldanamycin (GA), is a specific inhibitor of heat shock protein 90 (Hsp90) and is a potential anticancer agent. Since Plasmodium falciparum has been reported to have an Hsp90 ortholog, we tested the possibility that GA might inhibit it and thereby display antiparasitic activity.

RESULTS

We provide direct recombinant DNA evidence for the Hsp90 protein of Plasmodium falciparum, the causative agent of fatal malaria. While the mRNA of Hsp90 was mainly expressed in ring and trophozoite stages, the protein was found in all stages, although schizonts contained relatively lower amounts. In vitro the parasitic Hsp90 exhibited an ATP-binding activity that could be specifically inhibited by GA. Plasmodium growth in human erythrocyte culture was strongly inhibited by GA with an IC50 of 20 nM, compared to the IC50 of 15 nM for chloroquine (CQ) under identical conditions. When used in combination, the two drugs acted synergistically. GA was equally effective against CQ-sensitive and CQ-resistant strains (3D7 and W2, respectively) and on all erythrocytic stages of the parasite.

CONCLUSIONS

Together, these results suggest that an active and essential Hsp90 chaperone cycle exists in Plasmodium and that the ansamycin antibiotics will be an important tool to dissect its role in the parasite. Additionally, the favorable pharmacology of GA, reported in human trials, makes it a promising antimalarial drug.

摘要

背景

天然存在的苯醌安莎霉素化合物格尔德霉素(GA)是热休克蛋白90(Hsp90)的特异性抑制剂,是一种潜在的抗癌药物。由于据报道恶性疟原虫有一个Hsp90直系同源物,我们测试了GA可能抑制它并从而显示抗寄生虫活性的可能性。

结果

我们为致命疟疾的病原体恶性疟原虫的Hsp90蛋白提供了直接的重组DNA证据。虽然Hsp90的mRNA主要在环状体和滋养体阶段表达,但在所有阶段都发现了该蛋白,尽管裂殖体中的含量相对较低。在体外,寄生的Hsp90表现出一种ATP结合活性,可被GA特异性抑制。在人红细胞培养中,GA强烈抑制疟原虫生长,IC50为20 nM,而在相同条件下氯喹(CQ)的IC50为15 nM。联合使用时,这两种药物具有协同作用。GA对CQ敏感和CQ耐药菌株(分别为3D7和W2)以及疟原虫的所有红细胞内阶段同样有效。

结论

总之,这些结果表明疟原虫中存在一个活跃且必需的Hsp90伴侣循环,并且安莎霉素类抗生素将是剖析其在寄生虫中作用的重要工具。此外,在人体试验中报道的GA良好药理学特性使其成为一种有前景的抗疟药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/1fb784ae0093/1475-2875-2-30-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/d128ae802448/1475-2875-2-30-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/891fb945a2e8/1475-2875-2-30-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/1dccce189ca6/1475-2875-2-30-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/c82c089f0d1a/1475-2875-2-30-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/5127eef410f4/1475-2875-2-30-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/4c446f99d426/1475-2875-2-30-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/2fe4f9841489/1475-2875-2-30-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/1fb784ae0093/1475-2875-2-30-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/d128ae802448/1475-2875-2-30-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/891fb945a2e8/1475-2875-2-30-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/1dccce189ca6/1475-2875-2-30-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/c82c089f0d1a/1475-2875-2-30-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/5127eef410f4/1475-2875-2-30-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/4c446f99d426/1475-2875-2-30-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/2fe4f9841489/1475-2875-2-30-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/201030/1fb784ae0093/1475-2875-2-30-8.jpg

相似文献

1
The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin.恶性疟原虫热休克蛋白90及其抑制剂格尔德霉素的抗疟活性
Malar J. 2003 Sep 15;2:30. doi: 10.1186/1475-2875-2-30.
2
Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin.恶性疟原虫钙调神经磷酸酶及其与热休克蛋白90的关联:环孢素A的抗疟活性机制以及与格尔德霉素的协同作用
Mol Biochem Parasitol. 2005 May;141(1):29-37. doi: 10.1016/j.molbiopara.2005.01.012.
3
Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug.热休克蛋白 90 作为抗原生动物感染的药物靶点:恶性疟原虫和伊氏锥虫 HSP90 的生化特征及其抑制剂作为候选药物的评估。
J Biol Chem. 2010 Dec 3;285(49):37964-75. doi: 10.1074/jbc.M110.155317. Epub 2010 Sep 13.
4
Structure of the ATP-binding domain of Plasmodium falciparum Hsp90.疟原虫 Hsp90 的 ATP 结合域结构。
Proteins. 2010 Oct;78(13):2738-44. doi: 10.1002/prot.22799.
5
Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes.热休克蛋白90的功能对于恶性疟原虫在人类红细胞中的生长至关重要。
J Biol Chem. 2003 May 16;278(20):18336-45. doi: 10.1074/jbc.M211309200. Epub 2003 Feb 12.
6
Model System Identifies Kinetic Driver of Hsp90 Inhibitor Activity against African Trypanosomes and Plasmodium falciparum.模型系统鉴定 Hsp90 抑制剂对非洲锥虫和疟原虫活性的动力学驱动因素。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00056-18. Print 2018 Aug.
7
Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors.鉴定和表征热休克蛋白 90 抑制剂的抗疟原虫活性。
Malar J. 2017 Jul 19;16(1):292. doi: 10.1186/s12936-017-1940-7.
8
The complementation of yeast with human or Plasmodium falciparum Hsp90 confers differential inhibitor sensitivities.用人源或恶性疟原虫的Hsp90对酵母进行互补会赋予不同的抑制剂敏感性。
Mol Biochem Parasitol. 2009 Apr;164(2):147-52. doi: 10.1016/j.molbiopara.2008.12.011.
9
A purine analog synergizes with chloroquine (CQ) by targeting Plasmodium falciparum Hsp90 (PfHsp90).嘌呤类似物通过靶向疟原虫热休克蛋白 90(PfHsp90)与氯喹(CQ)协同作用。
PLoS One. 2013 Sep 30;8(9):e75446. doi: 10.1371/journal.pone.0075446. eCollection 2013.
10
Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.巴西朗多尼亚州抗疟药物的体外敏感性和疟原虫的基因特征:恶性疟原虫和间日疟原虫。
Malar J. 2014 Feb 28;13:73. doi: 10.1186/1475-2875-13-73.

引用本文的文献

1
Investigation of a cryptic ligand binding site on Plasmodium falciparum Hsp90.恶性疟原虫热休克蛋白90隐秘配体结合位点的研究。
Bioorg Med Chem. 2025 Aug 26;130:118371. doi: 10.1016/j.bmc.2025.118371.
2
Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome.疟原虫 Hsp90 的选择性靶向破坏 26S 蛋白酶体。
Cell Chem Biol. 2024 Apr 18;31(4):729-742.e13. doi: 10.1016/j.chembiol.2024.02.008. Epub 2024 Mar 15.
3
Pharmacophore Model-Based Virtual Screening Workflow for Discovery of Inhibitors Targeting Hsp90.

本文引用的文献

1
Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors.17-(烯丙胺基)-17-去甲氧基格尔德霉素在成年实体瘤患者中的I期及药理学研究。
J Clin Oncol. 2005 Mar 20;23(9):1885-93. doi: 10.1200/JCO.2005.12.085.
2
The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum.恶性疟原虫红细胞内发育周期的转录组
PLoS Biol. 2003 Oct;1(1):E5. doi: 10.1371/journal.pbio.0000005. Epub 2003 Aug 18.
3
The Hsp90 chaperone complex as a novel target for cancer therapy.
基于药效团模型的虚拟筛选工作流程用于发现靶向热休克蛋白90(Hsp90)的抑制剂
ACS Omega. 2023 Sep 26;8(41):38220-38232. doi: 10.1021/acsomega.3c04494. eCollection 2023 Oct 17.
4
Malaria therapeutics: are we close enough?疟疾治疗学:我们是否已足够接近?
Parasit Vectors. 2023 Apr 14;16(1):130. doi: 10.1186/s13071-023-05755-8.
5
Hsp90 and Associated Co-Chaperones of the Malaria Parasite.疟原虫的热休克蛋白90及其相关共伴侣蛋白
Biomolecules. 2022 Jul 22;12(8):1018. doi: 10.3390/biom12081018.
6
Inhibitors of the Hsp90 towards Selective Antimalarial Drug Design: The Past, Present and Future.Hsp90 抑制剂在选择性抗疟药物设计中的应用:过去、现在和未来。
Cells. 2021 Oct 22;10(11):2849. doi: 10.3390/cells10112849.
7
Heat Shock Proteins as Targets for Novel Antimalarial Drug Discovery.热休克蛋白作为新型抗疟药物发现的靶点。
Adv Exp Med Biol. 2021;1340:205-236. doi: 10.1007/978-3-030-78397-6_9.
8
Role of Heat Shock Proteins in Immune Modulation in Malaria.热休克蛋白在疟疾免疫调节中的作用。
Adv Exp Med Biol. 2021;1340:169-186. doi: 10.1007/978-3-030-78397-6_7.
9
The Role of Hsp70s in the Development and Pathogenicity of Plasmodium falciparum.Hsp70s 在疟原虫发育和致病中的作用。
Adv Exp Med Biol. 2021;1340:75-95. doi: 10.1007/978-3-030-78397-6_3.
10
Partners in Mischief: Functional Networks of Heat Shock Proteins of and Their Influence on Parasite Virulence.恶作剧的伙伴: 和 热休克蛋白的功能网络及其对寄生虫毒力的影响。
Biomolecules. 2019 Jul 23;9(7):295. doi: 10.3390/biom9070295.
热休克蛋白90伴侣复合体作为癌症治疗的新靶点。
Ann Oncol. 2003 Aug;14(8):1169-76. doi: 10.1093/annonc/mdg316.
4
A Plasmodium homologue of cochaperone p23 and its differential expression during the replicative cycle of the malaria parasite.伴侣蛋白p23的疟原虫同源物及其在疟原虫复制周期中的差异表达。
Parasitol Res. 2003 Jun;90(2):166-70. doi: 10.1007/s00436-003-0835-4. Epub 2003 Mar 12.
5
Development of small molecule Hsp90 inhibitors: utilizing both forward and reverse chemical genomics for drug identification.小分子热休克蛋白90(Hsp90)抑制剂的研发:运用正向和反向化学基因组学进行药物识别
Curr Med Chem. 2003 May;10(9):733-9. doi: 10.2174/0929867033457818.
6
Characterization of a unique aspartate-rich protein of the SET/TAF-family in the human malaria parasite, Plasmodium falciparum, which inhibits protein phosphatase 2A.
Mol Biochem Parasitol. 2003 Feb;126(2):239-50. doi: 10.1016/s0166-6851(02)00293-1.
7
Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes.热休克蛋白90的功能对于恶性疟原虫在人类红细胞中的生长至关重要。
J Biol Chem. 2003 May 16;278(20):18336-45. doi: 10.1074/jbc.M211309200. Epub 2003 Feb 12.
8
Plasmodium chloroquine resistance and the search for a replacement antimalarial drug.疟原虫氯喹耐药性与寻找替代抗疟药物
Science. 2002 Oct 4;298(5591):124-6. doi: 10.1126/science.1078167.
9
In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin.新型抗疟药物磷霉素与克林霉素的体内外协同作用
Antimicrob Agents Chemother. 2002 Sep;46(9):2889-94. doi: 10.1128/AAC.46.9.2889-2894.2002.
10
Natural substrates of the proteasome and their recognition by the ubiquitin system.蛋白酶体的天然底物及其被泛素系统识别的过程。
Curr Top Microbiol Immunol. 2002;268:137-74. doi: 10.1007/978-3-642-59414-4_6.